Correlation Between BioNexus Gene and NewMarket

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both BioNexus Gene and NewMarket at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining BioNexus Gene and NewMarket into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between BioNexus Gene Lab and NewMarket, you can compare the effects of market volatilities on BioNexus Gene and NewMarket and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in BioNexus Gene with a short position of NewMarket. Check out your portfolio center. Please also check ongoing floating volatility patterns of BioNexus Gene and NewMarket.

Diversification Opportunities for BioNexus Gene and NewMarket

-0.37
  Correlation Coefficient

Very good diversification

The 3 months correlation between BioNexus and NewMarket is -0.37. Overlapping area represents the amount of risk that can be diversified away by holding BioNexus Gene Lab and NewMarket in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on NewMarket and BioNexus Gene is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on BioNexus Gene Lab are associated (or correlated) with NewMarket. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of NewMarket has no effect on the direction of BioNexus Gene i.e., BioNexus Gene and NewMarket go up and down completely randomly.

Pair Corralation between BioNexus Gene and NewMarket

Given the investment horizon of 90 days BioNexus Gene Lab is expected to generate 6.86 times more return on investment than NewMarket. However, BioNexus Gene is 6.86 times more volatile than NewMarket. It trades about 0.03 of its potential returns per unit of risk. NewMarket is currently generating about -0.07 per unit of risk. If you would invest  43.00  in BioNexus Gene Lab on November 1, 2024 and sell it today you would lose (2.00) from holding BioNexus Gene Lab or give up 4.65% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

BioNexus Gene Lab  vs.  NewMarket

 Performance 
       Timeline  
BioNexus Gene Lab 

Risk-Adjusted Performance

4 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in BioNexus Gene Lab are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of rather inconsistent essential indicators, BioNexus Gene exhibited solid returns over the last few months and may actually be approaching a breakup point.
NewMarket 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days NewMarket has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest conflicting performance, the Stock's technical and fundamental indicators remain stable and the newest uproar on Wall Street may also be a sign of mid-term gains for the firm private investors.

BioNexus Gene and NewMarket Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with BioNexus Gene and NewMarket

The main advantage of trading using opposite BioNexus Gene and NewMarket positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if BioNexus Gene position performs unexpectedly, NewMarket can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in NewMarket will offset losses from the drop in NewMarket's long position.
The idea behind BioNexus Gene Lab and NewMarket pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.

Other Complementary Tools

Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Bonds Directory
Find actively traded corporate debentures issued by US companies
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like